United States Generic Drug Market Outlook

According to a new report by Expert Market Research titled, “United States Generic Drug Market Size, Share, Analysis, Report and Forecast 2024-2032″, the United States generic drug market reached a value of about USD 146.14 billion in 2023. Aided by rising incidences of chronic diseases and increasing number of generic drug approvals, the market is projected to further grow at a CAGR of 12% between 2024 and 2032 to reach a value of nearly USD 288.51 billion by 2032.

Generic drugs, a crucial part of the pharmaceutical industry, are identical—or bioequivalent—to a brand-name drug in dose, form, safety, route of administration, quality, and intended use, but do not carry the brand name. They provide the same therapeutic effects but at a significantly lower cost. This affordability combined with high quality makes them an invaluable choice for both healthcare providers and consumers.

Get a Free Sample Report with Table of Contents@
https://www.expertmarketresearch.com/reports/united-states-generic-drug-market/requestsample

The United States generic drug market trends suggest that there is an increasing shift towards the use of generics due to the escalating healthcare costs in the country. As the ageing population in the U.S. expands, so does the demand for medication. With the skyrocketing prices of branded medicines, generics have emerged as the more economically viable option for many, especially in chronic treatments.

Furthermore, the drive to enhance healthcare access across all sectors of the American population is augmenting the United States generic drug market growth. The government, through policies and initiatives, has been encouraging the use of generics. For instance, the FDA’s Generic Drug User Fee Amendments (GDUFA) ensures that high-quality, affordable generic drugs are available to the public, bolstering trust in these products.

The pharmaceutical companies in the U.S. have been focusing more on R&D for generics, spotting the rising United States generic drug market demand. With numerous renowned drugs losing patent protection, these companies are keen on capitalising on this opportunity, thus intensifying market competition but also expanding the availability of generics for various treatments.

Moreover, technological advancements in drug manufacturing and a rigorous approval process have ensured that generic drugs in the U.S. maintain a standard that is at par with their branded counterparts. This has only further increased their acceptance and application across various medical fields, offering patients an affordable yet effective treatment pathway.

Read Full Report with Table of Contents@
https://www.expertmarketresearch.com/reports/united-states-generic-drug-market

The robust distribution channels, encompassing retail pharmacies, hospital pharmacies, and online pharmacies, have streamlined the accessibility of generic drugs to the end consumer. The increasing presence of e-pharmacies and mail-order pharmacies are expected to further fuel the United States generic drug market size.

United States Generic Drug Market Segmentation

The market can be divided based on type, therapy area, drug delivery, and distribution channel.

Market Breakup by Type

• Unbranded
• Branded

Market Breakup by Therapy Area

• CNS
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

Market Breakup by Drug Delivery

• Oral
• Injectables
• Dermal/Topical
• Inhalers
• Others

Market Breakup by Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies

Competitive Landscape

The EMR report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the United States generic drug market. Some of the major players explored in the report by Expert Market Research are as follows:

• Teva Pharmaceuticals USA, Inc.
• Sandoz Inc.
• Sun Pharmaceutical Industries Ltd.
• Lupin Pharmaceuticals, Inc.
• Par Pharmaceutical
• Endo Pharmaceuticals
• Others

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.

Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.

Media Contact

Company Name: Claight Corporation
Contact Person: Christopher, Business Consultant
Email: [email protected]
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

The post United States Generic Drug Market Size, Share, Price, Growth, Analysis, Report, Forecast 2024-2032 appeared first on Claight Corporation.